Presesin联合降钙素原对脓毒症患儿28d病死率预测价值研究

杨帆, 刘君, 王丹, 等. Presesin联合降钙素原对脓毒症患儿28d病死率预测价值研究[J]. 临床急诊杂志, 2021, 22(1): 15-20. doi: 10.13201/j.issn.1009-5918.2021.01.004
引用本文: 杨帆, 刘君, 王丹, 等. Presesin联合降钙素原对脓毒症患儿28d病死率预测价值研究[J]. 临床急诊杂志, 2021, 22(1): 15-20. doi: 10.13201/j.issn.1009-5918.2021.01.004
YANG Fan, LIU Jun, WANG Dan, et al. Study on predictive value of presesin combined with PCT in 28-day mortality of children with sepsis[J]. J Clin Emerg, 2021, 22(1): 15-20. doi: 10.13201/j.issn.1009-5918.2021.01.004
Citation: YANG Fan, LIU Jun, WANG Dan, et al. Study on predictive value of presesin combined with PCT in 28-day mortality of children with sepsis[J]. J Clin Emerg, 2021, 22(1): 15-20. doi: 10.13201/j.issn.1009-5918.2021.01.004

Presesin联合降钙素原对脓毒症患儿28d病死率预测价值研究

  • 基金项目:

    秦皇岛市科技局基金项目(No:201805A064)

详细信息
    通讯作者: 刘君,E-mail:szclj007@163.com
  • 中图分类号: R737.9

Study on predictive value of presesin combined with PCT in 28-day mortality of children with sepsis

More Information
  • 目的:探讨可溶性白细胞分化抗原14亚型(sCD14-ST,Presepsin)联合降钙素原(PCT)检测在脓毒症患儿28 d预后评价中的应用价值。方法:收集我院儿科收住的确诊为脓毒症的患儿132例。记录患儿一般情况,小儿危重病例评分(PCIS),采集静脉血并检测Presepsin、PCT及其他相关炎症指标的表达情况。随访28 d,根据患儿生存情况分为生存组和死亡组。多因素Logistic回归分析与脓毒症患儿28 d病死率相关的指标。采用Pearson相关分析检验Presepsin、PCT与PCIS的相关性。ROC曲线分析比较各指标对脓毒症患儿预后评估的价值。结果:随访28 d后,132例患儿中有48例死亡,病死率为35.82%。死亡组患儿血清Presepsin、PCT、CRP及WBC表达水平明显高于生存组,而PCIS评分明显低于生存组,差异具有统计学意义(P<0.05)。多因素Logistic回归分析表明,Presepsin、PCT及PCIS评分是脓毒症患儿死亡的独立危险因素(P<0.05)。Pearson相关性分析表明,Presepsin(r=-0.736,P<0.05)和PCT(r=-532,P<0.05)表达水平与PCIS评分呈负相关。ROC曲线分析结果显示Presepsin、PCT及PCIS评分曲线下面积(AUC)分别为0.851(95%CI:0.771~0.934)、0.806(95%CI:0.751~0.867)和0.748(95%CI:0.657~0.839)。Presepsin联合PCT检测的AUC值为0.942(95%CI:0.838~0.991)明显优于单一Presepsin和PCT检测AUC值(P<0.05)。结论:Presepsin联合PCT检测在预测脓毒症患儿病死率时具有重要的临床参考价值。
  • 加载中
  • [1]

    Levy MM,Dellinger RP,Townsend SR,et al.The Surviving Sepsis Campaign:results of an international guideline-based performance improvement program targeting severe sepsis[J].Intensive Care Med,2010,36(2):222-231.

    [2]

    Fleischmann C,Scherag A,Adhikari NK,et al.Assessment of Global Incidence and Mortality of Hospital-treated Sepsis.Current Estimates and Limitations[J].Am J Respir Crit Care Med,2016,193(3):259-272.

    [3]

    郭玮,何煜婷,邵琦,等.联合血降钙素原、脑钠肽、D-二聚体及PCIS评分对评估儿童重症肺炎预后的价值[J].临床儿科杂志,2017,35(8):575-579.

    [4]

    Singer M,Deutschman CS,Seymour CW,et al.The Third International Consensus Definitions for Sepsis and Septic Shock(Sepsis-3)[J].JAMA,2016,315(8):801-810.

    [5]

    于航,朝鲁门其其格.PCT、Hs-CRP水平联合PCIS评分在儿童脓毒症中的诊断价值[J].贵州医科大学学报,2018,43(9):1101-1104.

    [6]

    中华医学会儿科学分会医院感染管理与控制专业委员会.血清降钙素原检测在儿童感染性疾病中的临床应用专家共识[J].中华儿科杂志,2019,57(1):9-15.

    [7]

    Enguix-Armada A,Escobar-Conesa R,García-De La Torre A,et al.Usefulness of several biomarkers in the management of septic patients:C-reactive protein,procalcitonin,presepsin and mid-regional pro-adrenomedullin[J].Clin Chem Lab Med,2016,54(1):163-168.

    [8]

    马力,孙自国,沈华强,等.可溶性白细胞分化抗原14亚型对脓毒性休克患者28 d死亡风险预测价值的研究[J].临床急诊杂志,2020,21(3):222-226.

    [9]

    中华医学会儿科学分会急救学组,中华医学会急诊医学分会儿科学组,中国医师协会儿童重症医师分会.儿童脓毒性休克(感染性休克)诊治专家共识(2015版)[J].中华儿科杂志,2015,53(8):576-580.

    [10]

    Rello J,Valenzuela-Sánchez F,Ruiz-Rodriguez M,et al.Sepsis:A Review of Advances in Management[J].Adv Ther,2017,34(11):2393-2411.

    [11]

    Miglietta F,Faneschi ML,Lobreglio G,et al.Procalcitonin,C-reactive protein and serum lactate dehydrogenase in the diagnosis of bacterial sepsis,SIRS an systemic candidiasis[J].Infez Med,2015,23(3):230-237.

    [12]

    Samsudin I,Vasikaran SD.Clinical Utility and Measurement of Procalcitonin[J].Clin Biochem Rev,2017,38(2):59-68.

    [13]

    黄晓雯,马力忠,莫庆仪,等.降钙素原和C反应蛋白在小儿脓毒症早期诊断及判断病情严重程度中的价值[J].西部医学,2017,29(5):627-631.

    [14]

    石晓娜,徐梅先,霍习敏,等.脓毒症患儿早期血清白介素1受体1和活性蛋白C及降钙素原表达水平及其临床意义研究[J].中国全科医学,2018,21(20):2459-2462.

    [15]

    全锦花,张新超,王红霞.白细胞分化抗原14亚型在老年急性感染患者诊断和预后评价中的作用[J].中华老年医学杂志,2019,38(3):246-250.

    [16]

    El-Madbouly AA,El Sehemawy AA,Eldesoky NA,et al.Utility of presepsin,soluble triggering receptor expressed on myeloid cells-1,and neutrophil CD64 for early detection of neonatal sepsis[J].Infect Drug Resist,2019,12:311-319.

    [17]

    Enguix-Armada A,Escobar-Conesa R,García-De La Torre A,et al.Usefulness of several biomarkers in the management of septic patients:C-reactive protein,procalcitonin,presepsin and mid-regional pro-adrenomedullin[J].Clin Chem Lab Med,2016,54(1):163-168.

    [18]

    Masson S,Caironi P,Spanuth E,et al.Presepsin(soluble CD14 subtype)and procalcitonin levels for mortality prediction in sepsis:data from the Albumin Italian Outcome Sepsis trial[J].Crit Care,2014,18(1):R6.

    [19]

    毛云,盛孝燕,朱红阳,等.血清降钙素原和可溶性髓样细胞触发受体-1及可溶性CD14亚型水平联合预测脓毒症患者28 d病死率的价值研究[J].中国全科医学,2017,20(36):4494-4500.

  • 加载中
计量
  • 文章访问数:  180
  • PDF下载数:  100
  • 施引文献:  0
出版历程
收稿日期:  2020-07-01

目录